Comparison of Outcomes of Percutaneous Mechanical Aspiration vs Tricuspid Valve Surgery in Drug Use–Associated Endocarditis of the Tricuspid Valve - Summary - MDSpire

Comparison of Outcomes of Percutaneous Mechanical Aspiration vs Tricuspid Valve Surgery in Drug Use–Associated Endocarditis of the Tricuspid Valve

  • By

  • Madeleine Purcell

  • Sergey Gnilopyat

  • Bhargav Makwana

  • Shivakumar Narayanan

  • April 25, 2025

  • 0 min

Share

Objective:

To compare short-term procedural and clinical outcomes of percutaneous mechanical aspiration (PMA) and tricuspid valve surgery in people who inject drugs (PWID) with infective endocarditis (IE), highlighting the significance of this comparison for clinical decision-making.

Key Findings:
  • PMA cohort had a higher proportion of females (66% vs 57%) and non-White race (32% vs 22.5%).
  • At 1 month postprocedure, surgical group had a lower death rate (2.5% vs 7.9%, P = .001), while PMA group had no heart block or pacemaker needs (0% vs 4%).
  • After propensity matching, differences in outcomes were not significant, emphasizing the need for careful interpretation of results.
  • At 1 year postprocedure, both groups had similar rates of heart failure, tricuspid insufficiency, and treatment for opioid use disorder.
Interpretation:

Short-term outcomes of PMA appear comparable to those of tricuspid valve surgery in PWID with tricuspid valve IE, suggesting PMA may be a viable alternative and warranting further exploration in clinical practice.

Limitations:
  • Study limited by sample size and potential confounding factors, including specific demographic and clinical variables.
  • Lack of long-term outcome data and rigorous criteria for PMA use in DUA-IE.
Conclusion:

Further studies with larger cohorts are needed to evaluate long-term outcomes between PMA and surgical interventions in PWID with infective endocarditis, particularly focusing on specific patient populations and treatment protocols.

Original Source(s)

Related Content